These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23226072)

  • 21. Pazopanib in sarcomas: expanding the PALETTE.
    Wilky BA; Meyer CF; Trent JC
    Curr Opin Oncol; 2013 Jul; 25(4):373-8. PubMed ID: 23666473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Making progress in a rare disease: emerging therapeutics in soft tissue sarcomas.
    Choe J; Riedel R
    F1000Res; 2018; 7():. PubMed ID: 30450193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Medical treatment of soft tissue sarcomas based on the histological subtype].
    Pápai Z
    Magy Onkol; 2014 Mar; 58(1):53-8. PubMed ID: 24712007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances and controversies in the management of soft tissue sarcomas.
    Demetri GD; Blay JY; Casali PG
    Future Oncol; 2017 Jan; 13(1s):3-11. PubMed ID: 27918199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular diagnostics in soft tissue sarcomas and gastrointestinal stromal tumors.
    Smith SM; Coleman J; Bridge JA; Iwenofu OH
    J Surg Oncol; 2015 Apr; 111(5):520-31. PubMed ID: 25772665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Aspects of Genetics, Molecular Biology and Clinical Oncology of Sarcomas.
    Houfková K; Hatina J
    Klin Onkol; 2020; 33(1):66-78. PubMed ID: 32075391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcoma.
    Hartmann JT; Patel S
    Drugs; 2005; 65(2):167-78. PubMed ID: 15631540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted therapies for sarcomas: new roles for the pathologist.
    Al-Zaid T; Somaiah N; Lazar AJ
    Histopathology; 2014 Jan; 64(1):119-33. PubMed ID: 24117526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of clinical factors associated with survival in patients with soft-tissue sarcoma receiving trabectedin.
    Simetić L; Blažičević K; Ladenhauser T; Golčić M; Majnarić T; Herceg D
    Anticancer Drugs; 2021 Nov; 32(10):1058-1066. PubMed ID: 34232944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted treatment with pazopanib in metastatic soft tissue sarcoma: Nearly complete response in two cases.
    Sedef AM; Köse F; Doğan Ö; Ergün T; Sezer A; Mertsoylu H; Muallaoğlu S; Beşen A; Özyilkan Ö
    Mol Clin Oncol; 2015 Mar; 3(2):400-402. PubMed ID: 25798275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase 1 clinical trials for sarcomas: the cutting edge.
    Subbiah V; Kurzrock R
    Curr Opin Oncol; 2011 Jul; 23(4):352-60. PubMed ID: 21519259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Therapeutics in the Treatment of Uterine Sarcoma.
    Bose S; Schwartz GK; Ingham M
    Am Soc Clin Oncol Educ Book; 2022 Apr; 42():900-909. PubMed ID: 35714303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New and emerging therapies for advanced or metastatic soft tissue sarcoma.
    Gettys SC; Anderson JE; Davis JE
    J Oncol Pharm Pract; 2014 Aug; 20(4):288-97. PubMed ID: 24022407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma.
    Kopp HG; Patel S; Brücher B; Hartmann JT
    Am J Clin Dermatol; 2008; 9(4):207-17. PubMed ID: 18572972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted treatment for advanced soft tissue sarcoma: profile of pazopanib.
    Rajendra R; Jones RL; Pollack SM
    Onco Targets Ther; 2013; 6():217-22. PubMed ID: 23524973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New therapeutic strategies for soft tissue sarcomas.
    von Mehren M
    Curr Treat Options Oncol; 2003 Dec; 4(6):441-51. PubMed ID: 14585225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing sarcoma: where have we come from and where are we going?
    Bleloch JS; Ballim RD; Kimani S; Parkes J; Panieri E; Willmer T; Prince S
    Ther Adv Med Oncol; 2017 Oct; 9(10):637-659. PubMed ID: 28974986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic Profiling and Clinical Outcomes of Targeted Therapies in Adult Patients with Soft Tissue Sarcomas.
    Kokkali S; Georgaki E; Mandrakis G; Valverde C; Theocharis S
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted therapies for the treatment of soft tissue sarcoma.
    Fuchs JW; Schulte BC; Fuchs JR; Agulnik M
    Front Oncol; 2023; 13():1122508. PubMed ID: 36969064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.
    Benson C; Ray-Coquard I; Sleijfer S; Litière S; Blay JY; Le Cesne A; Papai Z; Judson I; Schöffski P; Chawla S; Gil T; Piperno-Neumann S; Marréaud S; Dewji MR; van der Graaf WTA
    Gynecol Oncol; 2016 Jul; 142(1):89-94. PubMed ID: 27012429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.